These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 8248225

  • 21. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology.
    Kadokura A, Yamazaki T, Lemere CA, Takatama M, Okamoto K.
    Neuropathology; 2009 Oct; 29(5):566-73. PubMed ID: 19422539
    [Abstract] [Full Text] [Related]

  • 22. Aberrant GAP-43 gene expression in Alzheimer's disease.
    de la Monte SM, Ng SC, Hsu DW.
    Am J Pathol; 1995 Oct; 147(4):934-46. PubMed ID: 7573369
    [Abstract] [Full Text] [Related]

  • 23. Increased in vitro phosphorylation of a Mr 60,000 protein in brain from patients with Alzheimer disease.
    Saitoh T, Dobkins KR.
    Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9764-7. PubMed ID: 3467336
    [Abstract] [Full Text] [Related]

  • 24. The role of neurofibrillary tangles in Alzheimer disease.
    Brion JP.
    Acta Neurol Belg; 1998 Jun; 98(2):165-74. PubMed ID: 9686275
    [Abstract] [Full Text] [Related]

  • 25. Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis.
    Richey PL, Siedlak SL, Smith MA, Perry G.
    Biochem Biophys Res Commun; 1995 Mar 17; 208(2):657-63. PubMed ID: 7695621
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Altered p59Fyn kinase expression accompanies disease progression in Alzheimer's disease: implications for its functional role.
    Ho GJ, Hashimoto M, Adame A, Izu M, Alford MF, Thal LJ, Hansen LA, Masliah E.
    Neurobiol Aging; 2005 May 17; 26(5):625-35. PubMed ID: 15708437
    [Abstract] [Full Text] [Related]

  • 29. Aberrant protein phosphorylation and cytoarchitecture in Alzheimer's disease.
    Saitoh T, Iimoto D.
    Prog Clin Biol Res; 1989 May 17; 317():769-80. PubMed ID: 2690121
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A peptidyl-prolyl isomerase, FKBP12, accumulates in Alzheimer neurofibrillary tangles.
    Sugata H, Matsuo K, Nakagawa T, Takahashi M, Mukai H, Ono Y, Maeda K, Akiyama H, Kawamata T.
    Neurosci Lett; 2009 Aug 07; 459(2):96-9. PubMed ID: 19414059
    [Abstract] [Full Text] [Related]

  • 32. Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology.
    Walker DG, Lue LF, Tang TM, Adler CH, Caviness JN, Sabbagh MN, Serrano GE, Sue LI, Beach TG.
    Neurobiol Aging; 2017 Jun 07; 54():175-186. PubMed ID: 28390825
    [Abstract] [Full Text] [Related]

  • 33. Alzheimer's disease. The density of amygdalar neuritic plaques is associated with the severity of neurofibrillary pathology and the degree of beta-amyloid protein deposition in the cerebral cortex.
    Yilmazer-Hanke DM.
    Acta Anat (Basel); 1998 Jun 07; 162(1):46-55. PubMed ID: 9789108
    [Abstract] [Full Text] [Related]

  • 34. Formation of phospho-SAPK/JNK granules in the hippocampus is an early event in Alzheimer disease.
    Lagalwar S, Guillozet-Bongaarts AL, Berry RW, Binder LI.
    J Neuropathol Exp Neurol; 2006 May 07; 65(5):455-64. PubMed ID: 16772869
    [Abstract] [Full Text] [Related]

  • 35. Presenilin-1-immunoreactive neurons are preserved in late-onset Alzheimer's disease.
    Giannakopoulos P, Bouras C, Kövari E, Shioi J, Tezapsidis N, Hof PR, Robakis NK.
    Am J Pathol; 1997 Feb 07; 150(2):429-36. PubMed ID: 9033258
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Altered aspartate in Alzheimer neurofibrillary tangles.
    Payan IL, Chou SJ, Fisher GH, Man EH, Emory C, Frey WH.
    Neurochem Res; 1992 Feb 07; 17(2):187-91. PubMed ID: 1531702
    [Abstract] [Full Text] [Related]

  • 38. A quantitative study of neurofibrillary tangles, senile plaques and astrocytes in the hippocampal subdivisions and entorhinal cortex in Alzheimer's disease, normal controls and non-Alzheimer neuropsychiatric diseases.
    Muramori F, Kobayashi K, Nakamura I.
    Psychiatry Clin Neurosci; 1998 Dec 07; 52(6):593-9. PubMed ID: 9895207
    [Abstract] [Full Text] [Related]

  • 39. Distribution of precursor amyloid-beta-protein messenger RNA in human cerebral cortex: relationship to neurofibrillary tangles and neuritic plaques.
    Lewis DA, Higgins GA, Young WG, Goldgaber D, Gajdusek DC, Wilson MC, Morrison JH.
    Proc Natl Acad Sci U S A; 1988 Mar 07; 85(5):1691-5. PubMed ID: 3278324
    [Abstract] [Full Text] [Related]

  • 40. Developmental study of the expression of B50/GAP-43 in rat retina.
    Reh TA, Tetzlaff W, Ertlmaier A, Zwiers H.
    J Neurobiol; 1993 Jul 07; 24(7):949-58. PubMed ID: 8228972
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.